Inactief instrument

Andere talen Meridian Bioscience, Inc.

Aandelen

VIVO

US5895841014

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Meridian Bioscience, Inc. Drives Democratization of Next-Generation Sequencing with Reagents Enabling Ambient Temperature Shipping and Storage of Sequencing Kits	10/04
Meridian Bioscience, Inc. announced that it has received KRW 128.772575398 billion in funding	30/11
Meridian Bioscience, Inc. announced that it expects to receive KRW 128.772575393 billion in funding	22/11
Meridian Bioscience, Inc. announced that it has received KRW 258.225164381 billion in funding from Columbus Holding Company	28-07-23
Meridian Bioscience Continues Expansion of H. Pylori Diagnostic Testing Solutions with Fda Clearance of Premier Hpsa Flex	25-07-23
Meridian Bioscience Sets a New Sustainability Standard in Diagnostic Assay Development with the Launch of Two New Animal-Free Immunoassay Interference Blockers	25-07-23
Meridian Bioscience, Inc. announced that it expects to receive KRW 258.225164381 billion in funding	12-06-23
Meridian Bioscience, Inc. Announces FDA Clearance for Innovative Curian® Shiga Toxin Assay	19-04-23
MERIDIAN BIOSCIENCE INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	09-02-23
Meridian Bioscience, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	09-02-23
MERIDIAN BIOSCIENCE INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial S (form 8-K)	01-02-23
SD Biosensor, SJL Partners Acquire Meridian Bioscience	31-01-23
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience	31-01-23
Meridian Bioscience, Inc.(NasdaqGM:VIVO) dropped from NASDAQ Composite Index	31-01-23
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P Healthcare Equipment Select Industry Index	31-01-23
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P 600	31-01-23
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P Composite 1500	31-01-23
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P Global BMI Index	31-01-23
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P TMI Index	31-01-23
Meridian Bioscience, Inc.(NasdaqGS:VIVO) dropped from S&P 1000	31-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Meridian Bioscience, Inc.

Aandelen

VIVO

US5895841014

Andere talen

Filters